Laminin gamma 2 chain is an extracellular matrix protein that plays an important role in cell migration and tumor invasion. We report altered expression and characteristic localization of this chain in a series of 105 cases of intrahepatic cholangiocarcinomas examined immunohistochemically. All tumors were grossly classified into the following three types: intraductal growth type (n ¼ 9), periductal infiltrating type (n ¼ 8) and mass-forming type (n ¼ 88). The tumors exhibited three distinct staining types: basement membrane staining, cytoplasmic staining and stromal staining. The basement membranous staining of laminin gamma 2 chain was more frequent in biliary dysplasia, intraductal growth and periductal infiltrating type than in mass-forming type. The cytoplasmic staining of carcinoma cells was observed especially at the cancer-stromal interface or at the invasive front of tumors. Stromal staining of laminin gamma 2 chain was essentially localized in the stroma around cancer cells at the invasive area, and the expression was significantly correlated with tumor aggressive factors and a poor prognosis in patients with intrahepatic cholangiocarcinoma. We conclude that laminin gamma 2 chain exhibits aberrant expression in a stepwise manner through different aggressive stages of tumor progression.
Laminin-5, which consists of alpha 3, beta 3 and gamma 2 chains, is a major component of the basement membrane of epithelial tissues. [1] [2] [3] It plays important roles in the static adhesion of epithelial cells to the basement membrane and in the promotion of epithelial cells. 4, 5 The basement membrane has been considered to perform as a mechanical barrier against cancer cell invasion and, in contrast, the changes of the laminin distribution and composition have been associated with the malignant transformation of epithelia and cancer cell invasion. 6 Laminin gamma 2 chain plays a key role in cell migration during tumor invasion. Overexpression of laminin gamma 2 chain has been particularly demonstrated at the invasive front of various carcinomas, including colorectal, [7] [8] [9] [10] [11] gastric, 12 lung 13, 14 and pancreatic [15] [16] [17] adenocarcinomas, and head and neck, 18 tongue 19 and esophageal 20 squamous cell carcinomas. The prognostic indicator of its expression has been reported in several tumors. 7, 13, 19 However, the regulatory mechanism for the laminin gamma 2 chain expression in tumor progression is currently unresolved.
Intrahepatic cholangiocarcinoma is the second most common primary liver cancer, and the incidence and mortality rate of intrahepatic cholangiocarcinoma have been increasing worldwide in recent years. 21, 22 The prognosis of patients with cholangiocarcinoma is generally poor, although a minority subtype of intrahepatic cholangiocarcinoma showing an intraductal growth pattern had a more favorable prognosis when complete tumor resection was performed. 23, 24 Intraductal growth type of intrahepatic cholangiocarcinoma frequently preserve basement membrane and are microscopically noninvasive or minimally invasive. It is important to evaluate the basement membrane molecule associated with tumor invasion among intrahepatic cholangiocarcinomas with various degrees of tumor extension. Up to now, the expression of laminin gamma 2 chain in intrahepatic cholangiocarcinomas and its premalignant lesion has not been elucidated. We currently investigated the expression and localization of laminin gamma 2 chain of dysplastic biliary epithelium, intraductal growth, periductal infiltrating and mass-forming types of intrahepatic cholangiocarcinoma. We then compared the results with the clinicopathological parameters and survival rates.
Materials and methods

Tissue Specimens
Tumor specimens were obtained from 105 patients who had undergone surgery for cholangiocarcinoma between 1987 and 2002. We also obtained 26 cases of surgically resected liver specimens for hepatolithiasis. All specimens were obtained from files at the Department of Anatomic Pathology of Kyushu University. We did not include patients with cholangiocarcinoma arising from the bile duct confluence or the extrahepatic bile duct. Patients who underwent incomplete resection were also excluded from this study. The cases of hepatolithiasis showed various degrees of dysplastic biliary epithelia with an increased nucleo-cytoplasmic ratio, loss of nuclear polarity and nuclear hyperchromasia. These dysplastic features were mild to severe epithelial atypia without definitive evidence of malignant cells. Tissues were fixed in 10% formalin, embedded in paraffin and stained with hematoxylin and eosin for histological examination.
Gross and Histologic Classification
Based on the criteria of The Liver Cancer Study Group of Japan, 25 intrahepatic cholangiocarcinomas were grossly divided into the following three types: intraductal growth type, periductal infiltrating type and mass-forming type. If more than one type was found, the predominant type was recorded in order of the degree of involvement. In this study, intraductal growth type was histologically subclassified into intraductal growth without invasion into the basement membrane and intraductal growth with invasion to the liver parenchyma. Tumor size was recorded as the largest diameter in the fixed specimens. Histologic typing of tumors revealed eight papillary, 23 well-differentiated, 41 moderately differentiated and 33 poorly differentiated adenocarcinomas, according to their degree of papillary or tubular formation. The clinicopathologic parameters of the patients and tumors based on the gross features are summarized in Table 1 .
Immunohistochemistry
Sections (4 mm thick) were cut and deparaffinized through xylene and ethanol. After the endogenous peroxidase activity was blocked by methanol containing 0.3% hydrogen peroxidase for 30 min, the sections were treated with Protease XXIV (Sigma, St Louis, MO, USA) for 15 min at room temperature. The slides were exposed to 10% nonimmunized rabbit serum in phosphate-buffered saline (PBS) for 10 min, and then the sections were incubated overnight at 41C with mouse monoclonal antibody against laminin gamma 2 chain (D4B5, Chemicon, Temecula, CA, USA) at the concentration of 10 mg/ ml. The antibody was developed against amino-acid residues 382-608 of human laminin gamma 2 chain, and it recognizes the 150-and 105-kDa chain proteins. The labeled antigen was detected by a HistoFine kit (Nichirei Pharmaceutical, Tokyo, Japan) and visualized by the 3,3 0 -diaminobenzidine tetrahydrochloride (DAB) as a chromogen. No significant staining was observed in the negative controls, which were prepared using the mouse immunoglobulin at the same concentration.
Immunohistochemical Evaluation
We evaluated the sections containing the maximum diameter of the tumor and the tumor-nontumorous border. In the nine cases of intraductal growth type, IG, intraductal growth; PI, periductal infiltrating; MF, mass-forming.
Laminin gamma 2 expression in cholangiocarcinoma S Aishima et al we focused on the in situ components of the tumor without invasive cells. Carcinoma cells were often heterogeneous with respect to laminin gamma 2 chain staining within the same tumor. Localization of the laminin gamma 2 chain was divided into the staining of basement membrane, the staining of tumor cytoplasms and the staining of tumor stroma around the carcinoma cells. Expression of laminin gamma 2 chain was judged positive when more than 10% of clear membranous staining, cancer cell cytoplasmic staining or tumor stromal staining was present. All the hematoxylin and eosin-stained slides and the immunohistochemical slides were evaluated independently by three observers (SA, TT and MT), and the grading was evaluated without knowledge of the outcome of the patients.
Statistics
The correlation between laminin gamma 2 expression and clinicopathologic parameters was assessed by means of the w 2 test and Mann-Whitney's U-test. Disease-specific survival was taken as the period of survival between surgery and the date of the last follow-up or death by disease. Patients who were alive or had died of a cause other than cholangiocarcinoma were censored for analysis of diseasespecific survival. Survival curves were calculated by the Kaplan-Meier method, and the differences between the curves were analyzed by the log-rank test. Cox's proportional hazard model was used in the multivariate survival analysis. The results were considered significant if the P-value was o0.05.
Results
Biliary Dysplasia
No positive staining of laminin gamma 2 chain was detected in the basement membrane or cytoplasm of nondysplastic or nontumorous biliary epithelium (Figure 1a ). In 17 (65%) of the 26 cases showing dysplastic biliary epithelium, laminin gamma 2 chain appeared to be located in the basement membrane of glandular epithelium. Basement membrane underlying the dysplastic epithelium is continuously stained (Figure 1b) . In the 17 cases of positive basement membrane staining, two cases were positive in the cytoplasms of severely dysplastic epithelial cells.
Intraductal Growth Type of Intrahepatic Cholangiocarcinoma
The nine cases of intraductal growth type were classified as four intraductal growth without invasion and five intraductal growth with invasion to the liver parenchyma. In six of the in situ components of the tumor, most parts of the basement membrane surrounding neoplastic glands were intensely stained for laminin gamma 2 chain (Figure 1c) . In four cases, the cytoplasms of neoplastic glands were focally positive (Figure 1d ). This cytoplasmic staining pattern was observed only in cases of the intraductal growth type with invasion to the liver parenchyma (Table 2) .
Periductal Infiltrating Type of Intrahepatic Cholangiocarcinoma
The tumor exhibited three distinct staining types: basement membrane staining, cytoplasmic staining and stromal staining. In six cases, varying degrees of positive staining for laminin gamma 2 chain were detected in the basement membrane surrounding neoplastic glands (Figure 1e ). Cytoplasmic staining of carcinoma cells was observed in five cases, while stromal staining around carcinoma cells was observed in two cases ( Table 2 ). The positive staining of carcinoma cell cytoplasms or the stromal component was clearly detected in the invasive areas (Figure 1f ).
Mass-forming Type of Intrahepatic Cholangiocarcinoma
The staining of laminin gamma 2 chain for massforming type was essentially identical to that observed in the cytoplasms of carcinoma cells at the cancer-stromal interface or at the invasive front of tumors in 53 of 88 cases (Figure 1g ). We also found that tumors with microglandular structures or scattered individual cells showed more frequent laminin gamma 2 chain staining than tumors forming well-differentiated glandular structures. In 18 cases, focal or diffuse staining of the basement membrane surrounding neoplastic glands, preferentially well-differentiated tubular structures, was intensely stained, whereas in 21 cases, the stromal component around the carcinoma cells, especially in invasive areas, was positive for the laminin gamma 2 chain (Figure 1h ). This staining pattern was observed in many cases of poorly differentiated carcinoma.
Correlation between Laminin Gamma 2 Expression and Clinicopathologic Parameters
The results of the analysis of the correlation between laminin gamma 2 localization and the clinicopathological parameters are presented in Table 3 . The basement membrane expression of the laminin gamma 2 chain was significantly more frequent in well-differentiated carcinomas than in poorly differentiated carcinomas (P ¼ 0.0115). In contrast, the stromal expression was more frequent in poorly differentiated carcinomas than in papillary and well-differentiated carcinomas (P ¼ 0.0303). Other Figure 1 Immunohi stochemical results of laminin gamma 2 chain. No positive reaction was detected in the basement membrane or cytoplasm of normal epithelium (a). Basement membrane underlying the dysplastic epithelium is continuously stained (b). Intraductal growth type without invasion represents intense staining of basement membrane surrounding neoplastic glands (c). Intraductal growth type with invasion shows focally positive staining of the cytoplasm of neoplastic glands (d). Periductal infiltrating type shows mainly positive staining of basement membrane surrounding neoplastic glands (e), and partly positive staining of carcinoma cell cytoplasm at the invasive areas (f). In mass-forming type, the cytoplasmic staining of carcinoma cells is observed at the cancer-stromal interface or at the invasive front of a tumor (g), but the stromal component around the carcinoma cells is positively stained, especially in invasive areas (h).
Laminin gamma 2 expression in cholangiocarcinoma S Aishima et al pathologic parameters, lymphatic permeation (P ¼ 0.0002) and lymph node metastasis (P ¼ 0.0014) were significantly correlated with stromal expression of laminin gamma 2 chain. In addition, only the lymph node metastasis was significantly correlated with cytoplasmic expression of laminin gamma 2 chain (P ¼ 0.027).
Univariate and Multivariate Analysis of Prognostic Parameters
The results of the univariate analysis of the conventional prognostic factors for disease-specific survival are shown in Table 4 . We found that tumor size (Po0.0001), growth morphology (P ¼ 0.0167), histologic differentiation (Po0.0001), vascular invasion (P ¼ 0.0001), lymphatic permeation (Po0.0001) and lymph node metastasis (Po0.0001) exhibited prognostic implications. Stromal expression of laminin gamma 2 chain was also significantly correlated with a poor prognosis (P ¼ 0.0006), although cytoplasmic expression of laminin gamma 2 chain was not ( Figure 2 ). The prognostic parameters and laminin gamma 2 chain expression were analyzed using multivariate analysis. Tumor size (P ¼ 0.0067), histologic differentiation (P ¼ 0.0053), lymphatic permeation (P ¼ 0.0002) and lymph node metastasis (P ¼ 0.0009) were independent prognostic parameters (Table 5 ). Stromal expression of laminin gamma 2 chain is not an independent prognostic marker.
Discussion
In our study, the in situ component of intraductal growth type with stromal invasion showed focal cytoplasmic expression of carcinoma cells, whereas noninvasive intraductal growth types revealed no cytoplasmic expression of carcinoma cells. It has been shown that laminin gamma 2 chain expression in the in situ component of intraductal papillarymucinous tumors (IPMTs) of the pancreas tends to increase with tumor development. 15 The expression of intraductal components in both intraductal growth type of intrahepatic cholangiocarcinoma and IPMT had a similar pattern, which suggests that the cytoplasmic expression of carcinoma cells for laminin gamma 2 chain plays an important role in the progression from noninvasive intraductal tumor to an invasive tumor.
Tumor invasion is the basic indicator for progression from premalignant to malignant tumors. In this study, we considered the biliary dysplasia of hepatolithiasis to be a premalignant lesion. Previous reports noted that human colonic adenomas and various normal epithelial tissues show the basement membranous expression of laminin gamma 2, not cytoplasmic expression of this chain.
2,10 Our findings of dominant expression of laminin gamma 2 chain in basement membrane of biliary dysplastic epithelium and noninvasive intraductal growth type of intrahepatic cholangiocarcinoma suggest that the basement membranous type of laminin gamma 2 chain is associated with the anchorage of epithelial cells to the underlying basement membrane. However, very little has been reported about the lammain gamma 2 expression in premalignant lesions, such as colorectal adenoma and dysplasia, so further investigation into the role of laminin gamma 2 chain in the basement membrane of premalignant lesions is needed. Our data and previous studies also demonstrated that a well-differentiated adenocarcinoma component showed more frequent basement membrane staining than does a poorly differentiated adenocarcinoma. 12, 17 Laminin gamma 2 chain in basement membrane may maintain the differentiated phenotype of adenocarcinoma.
Laminin gamma 2 positive expression was observed in the basement membrane of normal gastric epithelia with the anti-laminin gamma 2 antibody, D4B5. 12 In our study, using the same antibody, basement membrane underlying normal biliary epithelia is not stained. Other studies showed that the non-neoplastic tissue, including pancreatic duct, colonic mucosa and mammary duct, fails to demonstrate laminin gamma 2 by immunohistochemical approach and in situ hybridization. 8, 15, 16 Soini et al 16 suggested that the concentration of laminin gamma 2 in non-neoplastic duct is so low that it cannot be detected by immunohistochemistry.
In our study, lamminin gamma 2 chain appeared to be expressed in the stromal component around the carcinoma cells within tumors. Koshikawa et al Laminin gamma 2 expression in cholangiocarcinoma S Aishima et al reported that most laminin gamma 2 chain was accumulated in the cytoplasms of the tumor cells; however, diffuse extracellular staining for the gamma 2 chain was detected in only limited poorly differentiated gastric adenocarcinomas. The authors indicated that a part of the laminin gamma 2 chain may be secreted into the tumor stroma from the carcinoma cells. The hypothesis is explained by other studies showing that extracellular stromal staining of laminin gamma 2 chain was detected by immunohistochemical analysis, but the signal for laminin gamma 2 chain m-RNA was not observed in the non-neoplastic stromal cells. 8 Furthermore, matrix metalloproteinase-2 (MMP2) and membrane-type 1 matrix metalloproteinase (MT1-MMP) are considered to be candidates for laminin gamma 2 processing protease. 26, 27 Processing of the 155-kd gamma 2 chain involves a cleavage within domain III leading to a 105-kd polypeptide. It appears that the resultant degraded laminin gamma 2 chain is an active form that enhances epithelial cell migration. 28 We used commercially available antibody against laminin gamma 2 chain, which recognizes the 150-and 105-kDa chain proteins. Therefore, the antibody is considered to react to the proteolytically processed form of laminin gamma 2 chain. Katayama et al 29 reported that degraded laminin gamma 2 chain after receiving proteolytic processing by MMPs may be released into circulation. According to these results, stromal accumulation of laminin gamma 2 chain in intrahepatic cholangiocarcinomas may result from a secreted and active form of laminin gamma 2 chain, which may be processed proteolytically. Our interesting results that stromal expression of laminin gamma 2 chain is correlated with a poorly differentiated tumor feature, invasive potential such as lymph node metastasis and lymphatic permeation suggest that stromal expression of laminin gamma 2 chain is a potential marker of aggressive behavior of intrahepatic cholangiocarcinomas.
We propose a progression model of intrahepatic cholangiocarcinoma according to the growth morphology and localization of laminin gamma 2 chain (Figure 3) . The basement membranous staining continues from premalignant lesions to malignant tumors and decreases in the advanced tumor stage. The cytoplasmic staining of carcinoma cells is correlated with the step of carcinoma invasion to the stroma and the formation of an invasive tumor. The stromal staining appeared in the more advanced stages of tumor. Laminin gamma 2 chain appears to exhibit aberrant expression in a stepwise manner through different aggressive stages of tumor progression. 
